23 Jul, 2026
According to Straits Research, the global animal genetics market size was valued at $6.85 billion in 2025 and is projected to grow from $7.28 billion in 2026 to $11.83 billion by 2034, registering a CAGR of 6.25% during the forecast period 2026–2034.
The global animal genetics market is witnessing robust growth, primarily driven by rapid advancements in genetic testing and sequencing technologies that streamline and enhance the precision of breeding programs. Breakthroughs such as next-generation sequencing and sophisticated reproductive methods are enabling more accurate genetic selection, resulting in healthier and more productive livestock.
Moreover, increasing government support and investment in modernizing animal breeding practices in several countries are fueling market expansion. Growing awareness among farmers and breeders about the financial benefits of genetically enhanced animals—such as improved growth performance and resistance to disease—is further boosting adoption rates. In addition, the rise of commercial livestock farming, particularly in developing regions, is amplifying demand for high-quality genetic traits to optimize production efficiency and profitability.
The rising global appetite for animal-based protein, particularly meat and dairy, is a key driver propelling growth in the animal genetics market. Factors like population growth, increasing disposable incomes, and accelerating urbanization are contributing to the shift toward high-protein diets around the world.
To meet this escalating demand, livestock producers are turning to genetically enhanced animals that offer superior traits, including faster growth, higher feed efficiency, and improved disease resistance. This trend is accelerating the adoption of advanced genetic technologies in animal breeding practices globally.
One of the most promising avenues in the global animal genetics market is the use of gene editing technologies to create disease-resistant livestock breeds. Tools such as CRISPR-Cas9 allow scientists to target and alter genes that contribute to disease vulnerability, resulting in healthier animals. This approach can lead to lower mortality rates, enhanced productivity, and reduced reliance on antibiotics and vaccines.
Such advancements are likely to drive wider commercial adoption of gene editing in livestock agriculture around the world.
North America holds a dominant position in the global animal genetics market, driven by advanced livestock breeding infrastructure and widespread adoption of genomic technologies. The region benefits from strong governmental and private investment in agricultural biotechnology. For instance, the USDA’s support for genomic selection in cattle has significantly improved dairy productivity. Companies like Genus PLC and Zoetis Inc. are pioneering genetic solutions, such as PRRS-resistant pigs and genomic testing kits for cattle.
Additionally, the growing consumer demand for high-quality meat and dairy products has led to an increase in genetically superior livestock. Furthermore, collaborations between academic institutions and genetic firms, such as the partnership between the University of California and Neogen Corporation, are fostering innovation. Moreover, the expanding pet adoption trend, particularly in the U.S., is also contributing to the demand for genetic testing in companion animals for breed profiling and hereditary disease screening.
sales@straitsresearch.com